Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial

Authors

Institutions

Publication Details

Journal
American Journal of Clinical Dermatology
Published
2024-10-23
DOI
https://doi.org/10.1007/s40257-024-00899-4
Citations
4
Primary Topic
Hair Growth and Disorders
Type
article
Field-Weighted Citation Impact
2.14

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial

Natasha Atanaskova Mesinkovska, Dalia Wajsbrot, Rodney Sinclair, Ernest H. Law et al.
4 citations
American Journal of Clinical Dermatology
Hair Growth and Disorders
2.14
article

Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial

Natasha Atanaskova Mesinkovska, Dalia Wajsbrot, Rodney Sinclair, Ernest H. Law, Debanjali Mitra, Robert A. Wolk, Brett King
article en
4 citations

Abstract

No abstract available for this paper.
American Journal of Clinical DermatologyVol. 26(1)
Pfizer (United States) (US), Yale University (US), UC Irvine Health (US), Sinclair Dermatology (AU)
Pfizer
Openalex Percentile: Top 13%
Hair Growth and Disorders
2.14
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.